Methods: We retrospectively reviewed 20 children (11 boys, 9 girls; mean age 5.48 years; range 39 days to 18 years) who underwent surgery for CCAM in our clinic between January 1999 and December 2012. Eleven patients had lobectomies (group 1), and nine patients had sublobar resections of whom six underwent thoracoscopic resections and three underwent open segmentectomy (group 2). Data were collected regarding age, sex, pathological diagnosis, location of lesion, surgical procedure, size of the lesion, chest tube duration, length of hospital stay, and postoperative complications.
Results: Although there was no statistically significant difference in the demographics between the two groups undergoing lobar and sublobar resection, the chest tube duration (5.3±0.5 days vs 3.6±1.9 days) and the length of hospital stay (7.5±0.7 vs 4.8±2.2 days) were significantly shorter in the sublobar resection group (p<0.05).
Conclusion: In our experience, both lobar and sublobar resections have similar clinical outcomes. Sublobar resections can be, therefore, easily performed thoracoscopically and can be safely applied to pediatric patients with CCAM.
Over the past decade, the video-assisted thoracoscopic surgery (VATS) which is an alternative to open procedures has yielded excellent results.[4] Meanwhile, sublobar parenchymal-saving resections have been also increasingly adopted.[5] Sublobar resections include resections containing part of a lobe (segmentectomy or wedge resection). Sublobar resections can be successfully performed in CCAMs via thoracoscopy.[6] Review of the literature revealed limited data on the sublobar resections of CCAMs in pediatric patients. Herein, we examined the efficacy of sublobar resections performed for CCAMs and discussed a series of lung resections for CCAMs performed in a single center.
Among 20 patients, group 1 consisted of 11 patients who underwent lobectomy, while group 2 consisted of nine patients who underwent sublobar resections (six thoracoscopic resections, three open segmentectomy resections).
All patients underwent preoperative computed tomography (CT). The patients with open resection underwent standard muscle-sparing posterolateral thoracotomy, as outlined elsewhere.[3] First, the segmental artery and bronchi were ligated and the segment with the lesion was, then, removed. Thoracoscopic operations were performed with selective lung intubation via three ports. Tissue divisions were adequately carried out with the combined use of a sealing device (LigaSure LS1000; Covidien) and rotaculator endoscopic staplers (Endo GIA Ultra Universal Stapler, Covidien Surgical, Mansfield, MA, USA). Outcome variables included the length of hospital stay, chest tube duration, and postoperative complications.
A routine postoperative CT was not performed on any of the patients, unless there was a respiratory problem and a request during the annual follow-up visit with plain chest radiography. The mean follow-up was 94.8 months (range 30 to 186 months).
Statistical analysis
The statistical analysis of the data was performed
by using the SPSS for Windows version 16.0 software
program (SPSS Inc., Chicago, IL, USA). The Fisher’s
exact test and Mann-Whitney U test were performed to
analyze abnormally distributed data. A 95% confidence
interval was accepted to be the confidence interval
and a p value of ≤0.05 was considered statistically
significant.
Table 1: Age, sex, location and size of lesion, access, surgical methods, and pathological diagnosis
Primary postoperative outcome variables, namely chest tube duration and length of hospital stay are also listed in Table 1. We found an increased chest tube duration and prolonged hospital stay in the lobectomy group, indicating a significant difference (p=0.045, p=0.021, respectively). No mortality or short-term complications were observed.
Recurrence was not observed in any of the patients during follow-up. Computed tomography results were able to be evaluated in only three patients who were admitted with lower respiratory system infection findings in the late period; these infections resolved with antibiotherapy. Two of these patients were lobectomy patients, while the other one had segmentectomy. No patients required second-look surgery.
Many authors used lung-sparing surgery to preserve lung tissue and to reduce morbidity eventually and reported that the early and late outcomes of the parenchyma-saving operations were excellent. Unlike our study, many of these surgeries included not only CCAMs, but also other CLMs, bronchopulmonary sequestration, bronchogenic and foregut cysts, bronchial atresia with distal cystic degeneration, and congenital lobar emphysema.[9-13]
The most common type of CCAM is type 1. In our series, the cases were either type 1 or 2. Type 1 cysts are larger than 2 cm and can be as large as 10 cm. These cysts are associated with malignant transformation.[14] One of the main reasons for elective resection for these lesions is their potential malignant nature. Therefore, all lesions are treated surgically, whereas they were treated conservatively and operated in the presence of complications in the past. We believe that the remaining tissue has a potential of development of malignancy.
Many studies have shown no differences between thoracotomy and thoracoscopy in terms of surgical outcome; however, thoracoscopy carries the advantages of being minimal invasive surgery, cosmesis, and muscle preservation in a growing child.[15-18] In the present study, three patients underwent thoracoscopic segmentectomies and we believe that segmentectomy in combination with thoracoscopy is a promising treatment of choice for the surgical management of CCAMs. Thanks to its lung-sparing potential, it may be convenient for thoracoscopy.
The main limitation of our study was the relatively small sample size. However, the types of lesions we studied are rare and all of our patients were pathologically diagnosed with CCAMs. Another limitation of our study was that our patients were unable to be analyzed for postoperative analgesia. Otherwise, we might possibly have proven that VATS yielded much better outcomes in postoperative analgesia.
In conclusion, parenchyma-sparing sublobar resections are appropriate alternatives which can be performed thoracoscopically and shorten the chest tube duration and length of hospital stay. We believe that lung-sparing surgery as sublobar resection may be sufficient in the treatment of CCAMs.
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this
article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Shanti CM, Klein MD. Cystic lung disease. Semin Pediatr
Surg 2008;17:2-8.
2) Coran AG, Drongowski R. Congenital cystic disease of the
tracheobronchial tree in infants and children. Experience
with 44 consecutive cases. Arch Surg 1994;129:521-7.
3) Jaureguizar E, Vazquez J, Murcia J, Diez Pardo JA.
Morbid musculoskeletal sequelae of thoracotomy for
tracheoesophageal fistula. J Pediatr Surg 1985;20:511-4.
4) Rothenberg SS. Thoracoscopic lung resection in children. J
Pediatr Surg 2000;35:271-4.
5) Dongel I, Ozkan B, Tanju S, Toker A. Pulmonary Sublober
resections in pediatric patients. Turk Gogus Kalp Dama
2014;22:99-103.
6) Işık AF, Şanlı M, Tunçözgür B, Akar E, Meteroğlu F,
Elbeyli L. Akciğerin doğumsal hastalıklarında tanı ve
cerrahi: 8 yıllık deneyimimiz, Turk Gogus Kalp Dama
2008;16:33-6.
7) Fitzgerald DA. Congenital cyst adenomatoid
malformations: resect some and observe all? Paediatr
Respir Rev 2007;8:67-76.
8) Zeidan S, Hery G, Lacroix F, Gorincour G, Potier A, Dubus
JC, et al. Intralobar sequestration associated with cystic
adenomatoid malformation: diagnostic and thoracoscopic
pitfalls. Surg Endosc 2009;23:1750-3.
9) Muller CO, Berrebi D, Kheniche A, Bonnard A. Is radical
lobectomy required in congenital cystic adenomatoid
malformation? J Pediatr Surg 2012;47:642-5.
10) Rothenberg SS, Shipman K, Kay S, Kadenhe-Chiweshe
A, Thirumoorthi A, Garcia A, et al. Thoracoscopic
segmentectomy for congenital and acquired pulmonary
disease: a case for lung-sparing surgery. J Laparoendosc Adv
Surg Tech A 2014;24:50-4.
11) Johnson SM, Grace N, Edwards MJ, Woo R, Puapong D.
Thoracoscopic segmentectomy for treatment of congenital
lung malformations. J Pediatr Surg 2011;46:2265-9.
12) Fascetti-Leon F, Gobbi D, Pavia SV, Aquino A, Ruggeri G,
Gregori G, et al. Sparing-lung surgery for the treatment of
congenital lung malformations. J Pediatr Surg 2013;48:1476-80.
13) Kim HK, Choi YS, Kim K, Shim YM, Ku GW, Ahn
KM, et al. Treatment of congenital cystic adenomatoid
malformation: should lobectomy always be performed? Ann
Thorac Surg 2008;86:249-53.
14) Kotecha S, Barbato A, Bush A, Claus F, Davenport M,
Delacourt C, et al. Antenatal and postnatal management of
congenital cystic adenomatoid malformation. Paediatr Respir
Rev 2012;13:162-70.
15) Diamond IR, Herrera P, Langer JC, Kim PC. Thoracoscopic
versus open resection of congenital lung lesions: a casematched
study. J Pediatr Surg 2007;42:1057-61.
16) Vu LT, Farmer DL, Nobuhara KK, Miniati D, Lee H.
Thoracoscopic versus open resection for congenital cystic
adenomatoid malformations of the lung. J Pediatr Surg
2008;4:35-9.